OBJECTIVE: Contemporary deep brain stimulation (DBS) for Parkinson's disease is delivered continuously, and adjustments based on patient's changing symptoms must be made manually by a trained clinician. Patients may be subjected to energy intensive settings at times when they are not needed, possibly resulting in stimulation-induced adverse effects, such as dyskinesia. One solution is 'adaptive' DBS, in which stimulation is modified in real time based on neural signals that co-vary with the severity of motor signs or of stimulation-induced adverse effects. Here we show the feasibility of adaptive DBS using a fully implanted neural prosthesis. APPROACH: We demonstrate adaptive deep brain stimulation in two patients with Parkinson's disease using a fully implanted neural prosthesis that is enabled to utilize brain sensing to control stimulation amplitude (Activa PC + S). We used a cortical narrowband gamma (60-90 Hz) oscillation related to dyskinesia to decrease stimulation voltage when gamma oscillatory activity is high (indicating dyskinesia) and increase stimulation voltage when it is low. MAIN RESULTS: We demonstrate the feasibility of 'adaptive deep brain stimulation' in two patients with Parkinson's disease. In short term in-clinic testing, energy savings were substantial (38%-45%), and therapeutic efficacy was maintained. SIGNIFICANCE: This is the first demonstration of adaptive DBS in Parkinson's disease using a fully implanted device and neural sensing. Our approach is distinct from other strategies utilizing basal ganglia signals for feedback control.
OBJECTIVE: Contemporary deep brain stimulation (DBS) for Parkinson's disease is delivered continuously, and adjustments based on patient's changing symptoms must be made manually by a trained clinician. Patients may be subjected to energy intensive settings at times when they are not needed, possibly resulting in stimulation-induced adverse effects, such as dyskinesia. One solution is 'adaptive' DBS, in which stimulation is modified in real time based on neural signals that co-vary with the severity of motor signs or of stimulation-induced adverse effects. Here we show the feasibility of adaptive DBS using a fully implanted neural prosthesis. APPROACH: We demonstrate adaptive deep brain stimulation in two patients with Parkinson's disease using a fully implanted neural prosthesis that is enabled to utilize brain sensing to control stimulation amplitude (Activa PC + S). We used a cortical narrowband gamma (60-90 Hz) oscillation related to dyskinesia to decrease stimulation voltage when gamma oscillatory activity is high (indicating dyskinesia) and increase stimulation voltage when it is low. MAIN RESULTS: We demonstrate the feasibility of 'adaptive deep brain stimulation' in two patients with Parkinson's disease. In short term in-clinic testing, energy savings were substantial (38%-45%), and therapeutic efficacy was maintained. SIGNIFICANCE: This is the first demonstration of adaptive DBS in Parkinson's disease using a fully implanted device and neural sensing. Our approach is distinct from other strategies utilizing basal ganglia signals for feedback control.
Authors: Nicole C Swann; Coralie de Hemptinne; Svjetlana Miocinovic; Salman Qasim; Sarah S Wang; Nathan Ziman; Jill L Ostrem; Marta San Luciano; Nicholas B Galifianakis; Philip A Starr Journal: J Neurosci Date: 2016-06-15 Impact factor: 6.167
Authors: Kai J Miller; Eric C Leuthardt; Gerwin Schalk; Rajesh P N Rao; Nicholas R Anderson; Daniel W Moran; John W Miller; Jeffrey G Ojemann Journal: J Neurosci Date: 2007-02-28 Impact factor: 6.167
Authors: Andrea A Kühn; Florian Kempf; Christof Brücke; Louise Gaynor Doyle; Irene Martinez-Torres; Alek Pogosyan; Thomas Trottenberg; Andreas Kupsch; Gerd-Helge Schneider; Marwan I Hariz; Wim Vandenberghe; Bart Nuttin; Peter Brown Journal: J Neurosci Date: 2008-06-11 Impact factor: 6.167
Authors: Jonathan B Shute; Michael S Okun; Enrico Opri; Rene Molina; P Justin Rossi; Daniel Martinez-Ramirez; Kelly D Foote; Aysegul Gunduz Journal: Neuroimage Clin Date: 2016-06-25 Impact factor: 4.881
Authors: Anders Christian Meidahl; Gerd Tinkhauser; Damian Marc Herz; Hayriye Cagnan; Jean Debarros; Peter Brown Journal: Mov Disord Date: 2017-06 Impact factor: 10.338
Authors: Daniel Martinez-Ramirez; Juan Giugni; Vinata Vedam-Mai; Aparna Wagle Shukla; Irene A Malaty; Nikolaus R McFarland; Ramon L Rodriguez; Kelly D Foote; Michael S Okun Journal: PLoS One Date: 2014-04-14 Impact factor: 3.240
Authors: Ashok Sriram; Kelly D Foote; Genko Oyama; Joshua Kwak; Pam R Zeilman; Michael S Okun Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2014-06-05
Authors: Enrico Opri; Stephanie Cernera; Rene Molina; Robert S Eisinger; Jackson N Cagle; Leonardo Almeida; Timothy Denison; Michael S Okun; Kelly D Foote; Aysegul Gunduz Journal: Sci Transl Med Date: 2020-12-02 Impact factor: 17.956
Authors: Ashan Veerakumar; Vineet Tiruvadi; Bryan Howell; Allison C Waters; Andrea L Crowell; Bradley Voytek; Patricio Riva-Posse; Lydia Denison; Justin K Rajendra; Johnathan A Edwards; Kelly R Bijanki; Ki Sueng Choi; Helen S Mayberg Journal: J Neurophysiol Date: 2019-07-17 Impact factor: 2.714
Authors: Walter Koroshetz; Joshua Gordon; Amy Adams; Andrea Beckel-Mitchener; James Churchill; Gregory Farber; Michelle Freund; Jim Gnadt; Nina S Hsu; Nicholas Langhals; Sarah Lisanby; Guoying Liu; Grace C Y Peng; Khara Ramos; Michael Steinmetz; Edmund Talley; Samantha White Journal: J Neurosci Date: 2018-06-19 Impact factor: 6.167
Authors: Andrea A Kühn; R Mark Richardson; Wolf-Julian Neumann; Robert S Turner; Benjamin Blankertz; Tom Mitchell Journal: Neurotherapeutics Date: 2019-01 Impact factor: 7.620
Authors: Morgan B Lee; Daniel R Kramer; Terrance Peng; Michael F Barbaro; Charles Y Liu; Spencer Kellis; Brian Lee Journal: J Clin Neurosci Date: 2019-07-30 Impact factor: 1.961